Search. Learn. Save

Platform for Pharmaceutical Products for Healthcare Professionals
Search By
☰ Generic Formulas

Generic Formulas X

Cephalexin Cefalexin

Cephalexin (Cefalexin): A Cornerstone in First-Generation Cephalosporin Antibiotics

Cephalexin, also spelled Cefalexin in many countries, is a well-established first-generation cephalosporin antibiotic that continues to play a vital role in modern medicine. Known for its efficacy, safety, and broad coverage against gram-positive pathogens, Cephalexin is a first-line agent for various bacterial infections, particularly those involving the skin, respiratory tract, urinary tract, and soft tissues. Despite the emergence of newer antibiotics and growing antimicrobial resistance, Cephalexin remains a popular choice among clinicians due to its oral bioavailability, cost-effectiveness, and reliable therapeutic outcomes.

1. Introduction to Cephalexin

Cephalexin is a β-lactam antibiotic in the cephalosporin class, specifically the first generation. Structurally and functionally related to penicillins, Cephalexin was developed to provide broader coverage against gram-positive bacteria while being resistant to penicillinases produced by many staphylococci. It was introduced in the 1960s and quickly gained global acceptance due to its versatility and safety profile, especially in penicillin-allergic patients (with certain exceptions).

2. Chemical and Structural Overview

  • IUPAC Name: (6R,7R)-7-[(2R)-2-amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

  • Molecular Formula: C16H17N3O4S

  • Molecular Weight: 347.39 g/mol

  • Drug Class: First-generation cephalosporin (β-lactam antibiotic)

The β-lactam ring in Cephalexin is essential for its antibacterial activity, enabling it to inhibit bacterial cell wall synthesis.

3. Mechanism of Action

Cephalexin exerts its antibacterial effects by:

  1. Inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs).

  2. Preventing the cross-linking of peptidoglycan chains, crucial components of the bacterial cell wall.

  3. Resulting in bacterial lysis and death, particularly in actively dividing cells.

Cephalexin is bactericidal, not merely bacteriostatic, meaning it actively kills bacteria rather than merely inhibiting growth.

4. Spectrum of Activity

Primarily Effective Against:

  • Gram-positive cocci:

    • Staphylococcus aureus (methicillin-sensitive)

    • Streptococcus pyogenes (Group A)

    • Streptococcus pneumoniae

Moderate to Low Activity Against:

  • Gram-negative bacilli:

    • Escherichia coli

    • Proteus mirabilis

    • Klebsiella pneumoniae

Ineffective Against:

  • Methicillin-resistant Staphylococcus aureus (MRSA)

  • Enterococcus spp.

  • Pseudomonas aeruginosa

  • Anaerobes and atypical bacteria

5. Pharmacokinetics

Absorption

  • Well absorbed orally (90–100%)

  • Food may delay peak concentration slightly but does not affect total absorption

Distribution

  • Widely distributed in tissues and fluids

  • Poor CNS penetration (not ideal for meningitis)

Metabolism

  • Minimal hepatic metabolism

Elimination

  • Primarily excreted unchanged in urine (via glomerular filtration and tubular secretion)

  • Half-life: ~1 hour (prolonged in renal impairment)

6. Dosage and Administration

Cephalexin is available in oral capsule, tablet, and suspension formulations.

Indication Adult Dose Pediatric Dose
Skin infections 500 mg every 6–12 hrs 25–50 mg/kg/day in divided doses
Respiratory tract infections 250–500 mg every 6–8 hrs 25–50 mg/kg/day
Urinary tract infections 500 mg every 12 hrs 25–50 mg/kg/day
Dental infections 500 mg every 6 hrs 25–50 mg/kg/day
Prophylaxis (endocarditis, surgery) Single 2 g dose 50 mg/kg

Note: Dose adjustments are needed in renal impairment.

7. Clinical Indications

7.1 Skin and Soft Tissue Infections

  • Most common indication

  • Effective against Staph and Strep species

  • Used in cellulitis, impetigo, abscesses (post-drainage)

7.2 Upper Respiratory Tract Infections

  • Pharyngitis, tonsillitis caused by Streptococcus pyogenes

  • Sinusitis (if caused by susceptible organisms)

7.3 Lower Respiratory Tract Infections

  • Limited to mild cases or as step-down oral therapy

7.4 Urinary Tract Infections

  • Uncomplicated UTIs due to E. coli or Proteus

7.5 Dental Infections

  • Widely used in dental abscesses and for prophylaxis in patients allergic to penicillin (without anaphylaxis)

7.6 Bone Infections

  • Osteomyelitis (short-term or step-down therapy)

8. Advantages of Cephalexin

  • Excellent oral bioavailability

  • Well tolerated even in pediatric and geriatric populations

  • Low cost and wide availability

  • Fewer drug interactions compared to other antibiotic classes

  • Safer alternative in non-severe penicillin allergy

9. Side Effects and Safety Profile

Common Side Effects

  • Gastrointestinal: nausea, vomiting, diarrhea

  • Headache

  • Vaginal candidiasis in females

Serious Adverse Effects

  • Hypersensitivity: rash, urticaria, rare anaphylaxis

  • Clostridium difficile-associated diarrhea (CDAD)

  • Seizures (rare, in high doses or renal failure)

  • Hemolytic anemia, thrombocytopenia (very rare)

Cephalexin is generally one of the better-tolerated antibiotics in outpatient care.

10. Cephalexin in Pregnancy and Breastfeeding

  • Pregnancy Category B (no proven risk in humans)

  • Safe in breastfeeding—low levels found in breast milk, no known adverse effects

It is often used in pregnant women with urinary tract infections, making it an essential option in obstetric practice.

11. Resistance and Limitations

Mechanisms of Resistance

  • β-lactamase production: hydrolyzes the β-lactam ring

  • Altered PBPs: decrease drug binding

  • Efflux pumps and reduced permeability in gram-negatives

Rising Resistance Trends

  • Increasing resistance among E. coli and Klebsiella

  • Ineffective against MRSA and ESBL-producing organisms

Judicious use is vital to preserving Cephalexin's efficacy, especially in community-acquired infections.

12. Drug Interactions

  • Probenecid: reduces renal excretion, increases Cephalexin levels

  • Metformin: possible increased serum levels; monitor renal function

  • Oral contraceptives: theoretical interaction; counsel additional contraception during use

13. Cephalexin vs. Other Antibiotics

Feature Cephalexin Amoxicillin Clindamycin Trimethoprim/Sulfamethoxazole
Class Cephalosporin Penicillin Lincosamide Sulfonamide
Gram+ Coverage Good Excellent Excellent Moderate
Gram− Coverage Moderate Good Poor Good
Anaerobes Poor Poor Good Poor
GI Tolerability High High Moderate Moderate
Resistance Issues Moderate High (esp. for E. coli) MRSA-resistant Increasing

14. Global Use and Essential Medicine Status

Cephalexin is included in the World Health Organization's (WHO) List of Essential Medicines due to its importance in treating common bacterial infections. It is used extensively in:

  • Community clinics

  • Emergency rooms

  • Pediatrics

  • Outpatient care in low-resource settings

Its inclusion in treatment guidelines underscores its global utility and clinical value.

15. Cephalexin in Pediatric Practice

Pediatricians frequently prescribe Cephalexin for:

  • Otitis media

  • Strep throat

  • Skin infections

  • Urinary tract infections

The availability of liquid suspension formulations makes it child-friendly, and its taste is generally well accepted.

16. Use in Dentistry

Dentists rely on Cephalexin for:

  • Post-operative prophylaxis

  • Dental abscesses

  • Periodontal infections

It is also a go-to alternative for patients with mild penicillin allergy who need dental antibiotic prophylaxis for endocarditis prevention.

17. Cephalexin and Antimicrobial Stewardship

Given its broad use, Cephalexin must be used responsibly:

  • Reserve for infections with susceptible organisms

  • Avoid in viral illnesses

  • Do not use empirically for MRSA

  • Educate patients about completing the full course

Antimicrobial stewardship programs often favor Cephalexin for step-down therapy after IV antibiotics, reducing hospitalization time and cost.

18. Future Outlook and Innovations

Despite its age, Cephalexin is experiencing a renaissance in the form of:

  • Combination therapies: With β-lactamase inhibitors

  • Prodrug formulations: Improving absorption

  • Nanotechnology: Enhanced delivery in targeted infections

  • AI-driven prescribing: Tailoring dose and duration based on algorithms

Its role in outpatient parenteral antimicrobial therapy (OPAT) is also evolving, as oral options reduce the need for IV antibiotics.

19. Conclusion

Cephalexin is a time-tested, versatile, and reliable antibiotic that continues to be a mainstay in treating uncomplicated infections. Its excellent safety profile, oral bioavailability, and effectiveness against common gram-positive organisms make it a first-choice agent in many clinical scenarios.While resistance trends demand cautious use, Cephalexin remains a critical component of modern antimicrobial therapy. With continued stewardship and research, it is poised to retain its place in global medicine for years to come.